Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 213

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Neurosteroids as regulators of neuroinflammation

Yilmaz, Canelif, Karali, Kanelina, Fodelianaki, Georgia, Gravanis, Achille, Chavakis, Triantafyllos, Charalampopoulos, Ioannis, Alexaki, Vasileia Ismini·2019·Frontiers in Neuroendocrinology
DOI 10.1016/j.yfrne.2019.100788
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yfrne.2019.100788

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY-NC-ND · From the PDF
Fig. 1 Functions and signaling of 17 β -estradiol in CNS cells. 17 β -estradiol derives in the CNS from neurons, astrocytes and the circulation (Zwain and Yen, 1999; Mellon and Gri ffi n, 2002; Schumacher et al., 2003; Starka et al., 2015). In microglia it can activate ER α and ER β mediating anti-in fl ammatory e ff ects by suppressing TNF, IL-6 or iNOS expression (Saijo et al., 2011; Smith et al., 2011; Brown et al., 2010; Soucy et al., 2005; Vegeto et al., 2001; Wu et al., 2016; Cerciat et al., 2010; Ishihara et al., 2015; Sarkaki et al., 2013; Barreto et al., 2007; Khaksari et al., 2011; Khaksari et al., 2015; Liu et al., 2005; Bruce-Keller et al., 2000; Sierra et al., 2008). Additionally, through the membrane receptor GPR30 it can activate rapid signaling events, such as Ca 2+ , cAMP or ERK signaling potentially mediating antiin fl ammatory e ff ects (Blasko et al., 2009; Guan et al., 2017; Alexaki et al., 2006; Schaufelberger et al., 2016; Zhang et al., 2018; Prossnitz and Barton, 2014; Prossnitz and Barton, 2011; Liu et al., 2013; Revankar et al., 2005; Filardo et al., 2000; Alexaki et al., 2004). 17 β -estradiol was also reported to negatively regulate infl ammasome activation by a yet unknown mechanism (Thakkar et al., 2016). In astrocytes it can activate ER α signaling diminishing chemokine expression (Spence et al., 2013; Spence et al., 2011; Kuo et al., 2010). The release of 17 β -estradiol is presented by a solid line and its e ff ects by a dashed line. Abbreviations: cAMP: cyclic adenosine monophosphate, CCL2: CC-chemokine ligand 2, CCL7: CC-chemokine ligand 7, ER α : estrogen receptor α , ER β : estrogen receptor β , Ε RK1/2: extracellular signal -regulated kinases 1/2, GPR30: G protein-coupled receptor 30, IL1 β : Interleukin 1 β , IL6: Interleukin 6, iNOS: inducible nitric oxide synthase, NLRP3: NLR family pyrin domain containing 3, TNF: Tumor Necrosis Factor.
Fig. 1 Functions and signaling of 17 β -estradiol in CNS cells. 17 β -estradiol derives in the CNS from neurons, astrocytes and the circulation (Zwain and Yen, 1999; Mellon and Gri ffi n, 2002; Schumacher et al., 2003; Starka et al., 2015). In microglia it can activate ER α and ER β mediating anti-in fl ammatory e ff ects by suppressing TNF, IL-6 or iNOS expression (Saijo et al., 2011; Smith et al., 2011; Brown et al., 2010; Soucy et al., 2005; Vegeto et al., 2001; Wu et al., 2016; Cerciat et al., 2010; Ishihara et al., 2015; Sarkaki et al., 2013; Barreto et al., 2007; Khaksari et al., 2011; Khaksari et al., 2015; Liu et al., 2005; Bruce-Keller et al., 2000; Sierra et al., 2008). Additionally, through the membrane receptor GPR30 it can activate rapid signaling events, such as Ca 2+ , cAMP or ERK signaling potentially mediating antiin fl ammatory e ff ects (Blasko et al., 2009; Guan et al., 2017; Alexaki et al., 2006; Schaufelberger et al., 2016; Zhang et al., 2018; Prossnitz and Barton, 2014; Prossnitz and Barton, 2011; Liu et al., 2013; Revankar et al., 2005; Filardo et al., 2000; Alexaki et al., 2004). 17 β -estradiol was also reported to negatively regulate infl ammasome activation by a yet unknown mechanism (Thakkar et al., 2016). In astrocytes it can activate ER α signaling diminishing chemokine expression (Spence et al., 2013; Spence et al., 2011; Kuo et al., 2010). The release of 17 β -estradiol is presented by a solid line and its e ff ects by a dashed line. Abbreviations: cAMP: cyclic adenosine monophosphate, CCL2: CC-chemokine ligand 2, CCL7: CC-chemokine ligand 7, ER α : estrogen receptor α , ER β : estrogen receptor β , Ε RK1/2: extracellular signal -regulated kinases 1/2, GPR30: G protein-coupled receptor 30, IL1 β : Interleukin 1 β , IL6: Interleukin 6, iNOS: inducible nitric oxide synthase, NLRP3: NLR family pyrin domain containing 3, TNF: Tumor Necrosis Factor.CC-BY-NC-ND · From the PDF
Fig. 2 Functions and signaling of progesterone and allopregnanolone in CNS cells. In the CNS progesterone and allopregnanolone derive from the periphery, astrocytes and oligodendrocytes (Zwain and Yen, 1999; Gago et al., 2001; Mellon and Gri ffi n, 2002; Schumacher et al., 2003; Starka et al., 2015). In microglia progesterone activates membrane PR α and PGMRC1 (Bali et al., 2013; Bali et al., 2013; Roche et al., 2016; Me ff re et al., 2013) and can down-regulate in fl ammasome activation, inhibit the expression of pro-in fl ammatory genes, such as TNF, IL-6, iNOS, MHCII and COX2, and enhance the expression of TREM2, CD206 or TGF β (Aryanpour et al., 2017; Lei et al., 2014; Cutler et al., 2007; Hua et al., 2011). Astrocytes express PR and PGMRC1 (Bali et al., 2013; Bali et al., 2013; Me ff re et al., 2005) and progesterone might induce BDNF release in a Pgrmc1-dependent manner, thereby promoting cell survival (Jodhka et al., 2009; Su et al., 2012; Sun et al., 2016; Kaur et al., 2007; Atif et al., 2013). On the other hand, allopregnanolone binds to GABAA receptors in microglia as well as astrocytes mediating antiin fl ammatory e ff ects through NF κ B inhibition (Singh et al., 2013; Lambert et al., 2003; Lee et al., 2011). The release of progesterone and allopregnanolone is marked by solid lines and their e ff ects by dashed lines. Abbreviations: BDNF: Brain-derived neurotrophic factor, CD206: Cluster of Di ff erentiation 206, COX2: cyclooxygenase 2, GABAAR: γ -aminobutyric acid type A receptor, IL1 β : Interleukin 1 β , IL6: Interleukin 6, iNOS: inducible nitric oxide synthase, MHCII: major histocompatibility complex class II, NLRP3: NLR family pyrin domain containing 3, mPR α : membrane progesterone receptor α , NF κ B: nuclear factor ' kappa-light-chain-enhancer ' of activated B-cells, NLRP3: NLR family pyrin domain containing 3, PGMRC1: progesterone membrane receptor component 1, PR: progesterone receptor, TGF β : Transforming Growth Factor β , TNF: Tumor Necrosis Factor, TREM2: Triggering receptor expressed on myeloid cells 2.
Fig. 2 Functions and signaling of progesterone and allopregnanolone in CNS cells. In the CNS progesterone and allopregnanolone derive from the periphery, astrocytes and oligodendrocytes (Zwain and Yen, 1999; Gago et al., 2001; Mellon and Gri ffi n, 2002; Schumacher et al., 2003; Starka et al., 2015). In microglia progesterone activates membrane PR α and PGMRC1 (Bali et al., 2013; Bali et al., 2013; Roche et al., 2016; Me ff re et al., 2013) and can down-regulate in fl ammasome activation, inhibit the expression of pro-in fl ammatory genes, such as TNF, IL-6, iNOS, MHCII and COX2, and enhance the expression of TREM2, CD206 or TGF β (Aryanpour et al., 2017; Lei et al., 2014; Cutler et al., 2007; Hua et al., 2011). Astrocytes express PR and PGMRC1 (Bali et al., 2013; Bali et al., 2013; Me ff re et al., 2005) and progesterone might induce BDNF release in a Pgrmc1-dependent manner, thereby promoting cell survival (Jodhka et al., 2009; Su et al., 2012; Sun et al., 2016; Kaur et al., 2007; Atif et al., 2013). On the other hand, allopregnanolone binds to GABAA receptors in microglia as well as astrocytes mediating antiin fl ammatory e ff ects through NF κ B inhibition (Singh et al., 2013; Lambert et al., 2003; Lee et al., 2011). The release of progesterone and allopregnanolone is marked by solid lines and their e ff ects by dashed lines. Abbreviations: BDNF: Brain-derived neurotrophic factor, CD206: Cluster of Di ff erentiation 206, COX2: cyclooxygenase 2, GABAAR: γ -aminobutyric acid type A receptor, IL1 β : Interleukin 1 β , IL6: Interleukin 6, iNOS: inducible nitric oxide synthase, MHCII: major histocompatibility complex class II, NLRP3: NLR family pyrin domain containing 3, mPR α : membrane progesterone receptor α , NF κ B: nuclear factor ' kappa-light-chain-enhancer ' of activated B-cells, NLRP3: NLR family pyrin domain containing 3, PGMRC1: progesterone membrane receptor component 1, PR: progesterone receptor, TGF β : Transforming Growth Factor β , TNF: Tumor Necrosis Factor, TREM2: Triggering receptor expressed on myeloid cells 2.CC-BY-NC-ND · From the PDF
Fig. 3 Functions and signaling of DHEA in CNS cells. DHEA is synthesized in astrocytes and neurons, while it also derives from the circulation (Zwain and Yen, 1999; Mellon and Gri ffi n, 2002; Schumacher et al., 2003; Starka et al., 2015). In microglia it exerts anti-in fl ammatory e ff ects through activation of the NGF receptor TrkA, which triggers the AKT/CREB signaling cascade leading to enhanced Jmjd3 expression (Lazaridis et al., 2011; Alexaki et al., 2018). Moreover, it can be metabolized to ADIOL, which binds to ER β thereby negatively regulating pro-in fl ammatory gene expression (Saijo et al., 2011). Through regulation of cytokine and NO secretion it a ff ects astrocyte activation and neuronal survival (Glass et al., 2010). The release of DHEA is shown by a solid line, its e ff ects by a dashed line. Abbreviations: ADIOL: 5-androstene-3 beta, 17 beta-diol, CREB: cAMP response element-binding protein, CtBP: C-terminal-binding protein 1, DHEA: Dehydroepiandrosterone, ER β : estrogen receptor β , HSD17 β 14: 17 β 14-Hydroxysteroid dehydrogenase, IL6: Interleukin 6, iNOS: inducible nitric oxide synthase, Jmjd3: Jumonji Domain Containing 3, TNF: Tumor Necrosis Factor, TrkA: tropomyosin related kinase.
Fig. 3 Functions and signaling of DHEA in CNS cells. DHEA is synthesized in astrocytes and neurons, while it also derives from the circulation (Zwain and Yen, 1999; Mellon and Gri ffi n, 2002; Schumacher et al., 2003; Starka et al., 2015). In microglia it exerts anti-in fl ammatory e ff ects through activation of the NGF receptor TrkA, which triggers the AKT/CREB signaling cascade leading to enhanced Jmjd3 expression (Lazaridis et al., 2011; Alexaki et al., 2018). Moreover, it can be metabolized to ADIOL, which binds to ER β thereby negatively regulating pro-in fl ammatory gene expression (Saijo et al., 2011). Through regulation of cytokine and NO secretion it a ff ects astrocyte activation and neuronal survival (Glass et al., 2010). The release of DHEA is shown by a solid line, its e ff ects by a dashed line. Abbreviations: ADIOL: 5-androstene-3 beta, 17 beta-diol, CREB: cAMP response element-binding protein, CtBP: C-terminal-binding protein 1, DHEA: Dehydroepiandrosterone, ER β : estrogen receptor β , HSD17 β 14: 17 β 14-Hydroxysteroid dehydrogenase, IL6: Interleukin 6, iNOS: inducible nitric oxide synthase, Jmjd3: Jumonji Domain Containing 3, TNF: Tumor Necrosis Factor, TrkA: tropomyosin related kinase.CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 297

  1. Abourbeh, 2012, Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [(1)(8)F]DPA-714, J. Neurosci., 32, 5728, 10.1523/JNEUROSCI.2900-11.2012 · DOI
  2. Abud, 2017, iPSC-derived human microglia-like cells to study neurological diseases, Neuron, 94, 278, 10.1016/j.neuron.2017.03.042 · DOI · Paper page
  3. Adeosun, 2012, Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease, PLoS ONE, 7, e50040, 10.1371/journal.pone.0050040 · DOI
  4. Aggelakopoulou, 2016, ERbeta in CD4+ T cells is crucial for ligand-mediated suppression of central nervous system autoimmunity, J. Immunol., 196, 4947, 10.4049/jimmunol.1600246 · DOI
  5. Aggelakopoulou, 2016, ERbeta-dependent direct suppression of human and murine Th17 cells and treatment of established central nervous system autoimmunity by a neurosteroid, J. Immunol., 197, 2598, 10.4049/jimmunol.1601038 · DOI
  6. Ahmad, 2013, Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice, PLoS ONE, 8, e57208, 10.1371/journal.pone.0057208 · DOI
  7. Ajami, 2007, Local self-renewal can sustain CNS microglia maintenance and function throughout adult life, Nat. Neurosci., 10, 1538, 10.1038/nn2014 · DOI · Paper page
  8. Aldred, 2010, Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients, Arch. Gerontol. Geriat., 51, E16, 10.1016/j.archger.2009.07.001 · DOI
  9. Alexaki, 2004, Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation, FASEB J., 18, 1594, 10.1096/fj.04-1495fje · DOI
  10. Alexaki, 2006, Activation of membrane estrogen receptors induce pro-survival kinases, J. Steroid. Biochem. Mol. Biol., 98, 97, 10.1016/j.jsbmb.2005.08.017 · DOI
  11. Alexaki, 2009, Dehydroepiandrosterone protects human keratinocytes against apoptosis through membrane binding sites, Exp. Cell Res., 315, 2275, 10.1016/j.yexcr.2009.04.006 · DOI
  12. Alexaki, 2017, DHEA inhibits acute microglia-mediated inflammation through activation of the TrkA-Akt1/2-CREB-Jmjd3 pathway, Mol. Psychiatry
  13. Alexaki, 2018, DHEA inhibits acute microglia-mediated inflammation through activation of the TrkA-Akt1/2-CREB-Jmjd3 pathway, Mol. Psychiatry, 23, 1410, 10.1038/mp.2017.167 · DOI
  14. Almolda, 2015, Are microglial cells the regulators of lymphocyte responses in the CNS?, Front. Cell. Neurosci., 9, 440, 10.3389/fncel.2015.00440 · DOI · Paper page
  15. Alvarez, 2013, Glial influence on the blood brain barrier, Glia, 61, 1939, 10.1002/glia.22575 · DOI
  16. Aryanpour, 2017, Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model, Int. Immunopharmacol., 51, 131, 10.1016/j.intimp.2017.08.007 · DOI
  17. Atif, 2013, Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: The role of BDNF/TrkB/Erk1/2 signaling in neuroprotection, Neuropharmacology, 67, 78, 10.1016/j.neuropharm.2012.10.004 · DOI
  18. Bali, 2013, Pgrmc1: new roles in the microglial mediation of progesterone-antagonism of estradiol-dependent neurite sprouting and in microglial activation, Front. Neurosci., 7, 157, 10.3389/fnins.2013.00157 · DOI
  19. Bali, 2013, Progesterone antagonism of neurite outgrowth depends on microglial activation via Pgrmc1/S2R, Endocrinology, 154, 2468, 10.1210/en.2012-2109 · DOI
  20. Barger, 2000, Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner, J. Neurosci. Res., 62, 503, 10.1002/1097-4547(20001115)62:4<503::AID-JNR4>3.0.CO;2-A · DOI
  21. Barreto, 2007, Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone, Eur. J Neurosci., 25, 3039, 10.1111/j.1460-9568.2007.05563.x · DOI
  22. Barron, 2012, Sex hormones, aging, and Alzheimer's disease, Front. Biosci. (Elite Ed), 4, 976
  23. Barrou, 1997, Dehydroepiandrosterone (DHEA) and aging, Arch. Gerontol. Geriat., 24, 233, 10.1016/S0167-4943(96)00761-3 · DOI
  24. Batchelor, 1999, Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor, J. Neurosci., 19, 1708, 10.1523/JNEUROSCI.19-05-01708.1999 · DOI
  25. Beaule, 2011, In vitro circadian rhythms: imaging and electrophysiology, Essays Biochem., 49, 103
  26. Bebo, 2001, Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains, J. Immunol., 166, 2080, 10.4049/jimmunol.166.3.2080 · DOI · Paper page
  27. Belanger, 2003, Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys, Endocrine, 21, 97, 10.1385/ENDO:21:1:97 · DOI
  28. Belanger, 2006, DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys, Neurobiol. Aging., 27, 1684, 10.1016/j.neurobiolaging.2005.09.028 · DOI
  29. Benedek, 2017, Novel feedback loop between M2 macrophages/microglia and regulatory B cells in estrogen-protected EAE mice, J. Neuroimmunol., 305, 59, 10.1016/j.jneuroim.2016.12.018 · DOI
  30. Bennett, 2016, Pharmacological properties of microneurotrophin drugs developed for treatment of amyotrophic lateral sclerosis, Biochem. Pharmacol., 117, 68, 10.1016/j.bcp.2016.08.001 · DOI
  31. Bjelobaba, 2018, Animal models of multiple sclerosis: focus on experimental autoimmune encephalomyelitis, J. Neurosci. Res., 96, 1021, 10.1002/jnr.24224 · DOI
  32. Blackshear, 2018, Exogenous progesterone is neuroprotective following injury to the male zebra finch brain, J. Neurosci. Res., 96, 545, 10.1002/jnr.24060 · DOI
  33. Blasko, 2009, Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis, J. Neuroimmunol., 214, 67, 10.1016/j.jneuroim.2009.06.023 · DOI
  34. Blesa, 2014, Parkinson's disease: animal models and dopaminergic cell vulnerability, Front. Neuroanat., 8, 155, 10.3389/fnana.2014.00155 · DOI
  35. Boghozian, 2017, Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: implications for regulation of neuroinflammation, Glia., 65, 1590, 10.1002/glia.23179 · DOI
  36. Bonetto, 2017, The novel synthetic microneurotrophin BNN27 protects mature oligodendrocytes against cuprizone-induced death, through the NGF receptor TrkA, GLIA, 10.1002/glia.23170 · DOI
  37. Botsakis, 2017, BNN-20, a synthetic microneurotrophin, strongly protects dopaminergic neurons in the “weaver” mouse, a genetic model of dopamine-denervation, acting through the TrkB neurotrophin receptor, Neuropharmacology, 121, 140, 10.1016/j.neuropharm.2017.04.043 · DOI
  38. Bourque, 2016, Neuroprotective effect of progesterone in MPTP-treated male mice, Neuroendocrinology, 103, 300, 10.1159/000438789 · DOI
  39. Bourque, 2018, Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease, Neuropharmacology
  40. Brinton, 2013, Neurosteroids as regenerative agents in the brain: therapeutic implications, Nat. Rev. Endocrinol., 9, 241, 10.1038/nrendo.2013.31 · DOI
  41. Brotfain, 2016, Neuroprotection by estrogen and progesterone in traumatic brain injury and spinal cord injury, Curr. Neuropharmacol., 14, 641, 10.2174/1570159X14666160309123554 · DOI
  42. Brown, 2010, Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta, Endocrinology, 151, 4916, 10.1210/en.2010-0371 · DOI
  43. Bruce-Keller, 2000, Antiinflammatory effects of estrogen on microglial activation, Endocrinology, 141, 3646, 10.1210/endo.141.10.7693 · DOI
  44. Bruce-Keller, 2007, Gender and estrogen manipulation do not affect traumatic brain injury in mice, J. Neurotrauma., 24, 203, 10.1089/neu.2006.0163 · DOI
  45. Caggiu, 2019, Inflammation, infectious triggers, and Parkinson's disease, Front Neurol., 10, 122, 10.3389/fneur.2019.00122 · DOI
  46. Callard, 1978, Phylogenetic distribution of aromatase and other androgen-converting enzymes in the central nervous system, Endocrinology, 103, 2283, 10.1210/endo-103-6-2283 · DOI
  47. Calogeropoulou, 2009, Novel dehydroepiandrosterone derivatives with antiapoptotic, neuroprotective activity, J. Med. Chem., 10.1021/jm900468p · DOI
  48. Cardounel, 1999, Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action, Proc. Soc. Exp. Biol. Med., 222, 145, 10.1046/j.1525-1373.1999.d01-124.x · DOI
  49. Carroll, 2007, Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice, J. Neurosci., 27, 13357, 10.1523/JNEUROSCI.2718-07.2007 · DOI
  50. Carroll, 2010, Continuous and cyclic progesterone differentially interact with estradiol in the regulation of alzheimer-like pathology in female 3×transgenic-Alzheimer’s disease mice, Endocrinology, 151, 2713, 10.1210/en.2009-1487 · DOI
  51. Caruso, 2013, Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats, Psychoneuroendocrinology, 38, 2278, 10.1016/j.psyneuen.2013.04.016 · DOI
  52. Casas, 2011, Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats, Pharmacol. Biochem. Behav., 99, 614, 10.1016/j.pbb.2011.06.012 · DOI
  53. Casper, 2007, Characterization of astrocyte-specific conditional knockouts, Genesis., 45, 292, 10.1002/dvg.20287 · DOI
  54. Castano, 1998, Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system, J. Neurochem., 70, 1584, 10.1046/j.1471-4159.1998.70041584.x · DOI
  55. Ceni, 2014, Neurotrophins in the regulation of cellular survival and death, Handb. Exp. Pharmacol., 220, 193, 10.1007/978-3-642-45106-5_8 · DOI
  56. Cerciat, 2010, Selective estrogen receptor modulators decrease the production of interleukin-6 and interferon-gamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro, Glia, 58, 93, 10.1002/glia.20904 · DOI
  57. Charalampopoulos, 2004, Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins, Proc. Natl. Acad. Sci. USA, 101, 8209, 10.1073/pnas.0306631101 · DOI
  58. Charalampopoulos, 2006, Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging, Ann. NY Acad. Sci., 1088, 139, 10.1196/annals.1366.003 · DOI
  59. Charalampopoulos, 2006, G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone, FASEB J., 20, 577, 10.1096/fj.05-5078fje · DOI
  60. Charalampopoulos, 2006, Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging, Neuroendocrine Immune Crosstalk, 1088, 139
  61. Charalampopoulos, 2008, Neurosteroids as modulators of neurogenesis and neuronal survival, Trends Endocrinol. Metab., 19, 300, 10.1016/j.tem.2008.07.004 · DOI
  62. Charalampopoulos, 2004, Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins, PNAS, 101, 8209, 10.1073/pnas.0306631101 · DOI
  63. Chen, 2005, Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease, Ann Neurol., 58, 963, 10.1002/ana.20682 · DOI
  64. Chen, 2005, Direct agonist/antagonist functions of dehydroepiandrosterone, Endocrinology, 146, 4568, 10.1210/en.2005-0368 · DOI
  65. Chen, 2011, Allopregnanolone promotes regeneration and reduces beta-amyloid burden in a preclinical model of Alzheimer's disease, PLoS ONE, 6, 10.1371/journal.pone.0024293 · DOI
  66. Chen, 2016, Tumor necrosis factor alpha induces neural stem cell apoptosis through activating p38 MAPK pathway, Neurochem. Res., 41, 3052, 10.1007/s11064-016-2024-8 · DOI
  67. Chen, 2003, Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease, Arch Neurol., 60, 1059, 10.1001/archneur.60.8.1059 · DOI
  68. Choi, 2015, Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination, Mol. Psychiatry, 20, 880, 10.1038/mp.2014.146 · DOI
  69. Citron, 2010, Alzheimer's disease: strategies for disease modification, Nat. Rev. Drug. Discov., 9, 387, 10.1038/nrd2896 · DOI
  70. Clevenger, 2018, Endogenous sex steroids dampen neuroinflammation and improve outcome of traumatic brain injury in mice, J. Mol. Neurosci., 64, 410, 10.1007/s12031-018-1038-x · DOI
  71. Colombo, 2016, Astrocytes: key regulators of neuroinflammation, Trends Immunol., 37, 608, 10.1016/j.it.2016.06.006 · DOI
  72. Cook, 2018, Crosstalk between estrogen withdrawal and NFkappaB signaling following penetrating brain injury, NeuroImmunoModulation, 25, 193, 10.1159/000493506 · DOI
  73. Corpechot, 1981, Characterization and measurement of dehydroepiandrosterone sulfate in rat brain, Proc. Natl. Acad. Sci. USA, 78, 4704, 10.1073/pnas.78.8.4704 · DOI · Paper page
  74. Cutler, 2007, Progesterone improves acute recovery after traumatic brain injury in the aged rat, J. Neurotrauma., 24, 1475, 10.1089/neu.2007.0294 · DOI
  75. D'Astous, 2003, Dehydroepiandrosterone (DHEA) such as 17 beta-estradiol prevents MPTP-induced dopamine depletion in mice, Synapse, 47, 10, 10.1002/syn.10145 · DOI
  76. Dhandapani, 2005, Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways, Endocrinology, 146, 2749, 10.1210/en.2005-0014 · DOI
  77. di Michele, 2003, Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson's disease, Neurol. Sci., 24, 172, 10.1007/s10072-003-0115-1 · DOI
  78. Diotel, 2011, Activity and expression of steroidogenic enzymes in the brain of adult zebrafish, Eur. J. Neurosci., 34, 45, 10.1111/j.1460-9568.2011.07731.x · DOI
  79. Dobson, 2019, Multiple sclerosis – a review, Eur. J. Neurol., 26, 27, 10.1111/ene.13819 · DOI
  80. Doerflinger, 2003, Inducible site-specific recombination in myelinating cells, Genesis, 35, 63, 10.1002/gene.10154 · DOI
  81. Du, 2001, Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice, J. Immunol., 167, 7094, 10.4049/jimmunol.167.12.7094 · DOI
  82. Elkabes, 1996, Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function, J. Neurosci., 16, 2508, 10.1523/JNEUROSCI.16-08-02508.1996 · DOI
  83. Eltzschig, 2012, Purinergic signaling during inflammation, N. Engl. J. Med., 367, 2322, 10.1056/NEJMra1205750 · DOI
  84. Emerson, 1993, Estrogen improves biochemical and neurologic outcome following traumatic brain injury in male rats, but not in females, Brain Res., 608, 95, 10.1016/0006-8993(93)90778-L · DOI
  85. Engler-Chiurazzi, 2017, Estrogens as neuroprotectants: estrogenic actions in the context of cognitive aging and brain injury, Prog. Neurobiol., 157, 188, 10.1016/j.pneurobio.2015.12.008 · DOI
  86. Farr, 2004, DHEAS improves learning and memory in aged SAMP8 mice but not in diabetic mice, Life Sci., 75, 2775, 10.1016/j.lfs.2004.05.026 · DOI
  87. Ferreira, 2018, Microglia response during Parkinson's disease: alpha-synuclein intervention, Front. Cell Neurosci., 12, 247, 10.3389/fncel.2018.00247 · DOI
  88. Filardo, 2000, Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF, Mol. Endocrinol., 14, 1649, 10.1210/mend.14.10.0532 · DOI
  89. Fletcher, 2010, T cells in multiple sclerosis and experimental autoimmune encephalomyelitis, Clin. Exp. Immunol., 162, 1, 10.1111/j.1365-2249.2010.04143.x · DOI
  90. Fodelianaki, 2019, Nerve growth factor modulates LPS – induced microglial glycolysis and inflammatory responses, Exp. Cell Res., 377, 10, 10.1016/j.yexcr.2019.02.023 · DOI
  91. Forlano, 2001, Anatomical distribution and cellular basis for high levels of aromatase activity in the brain of teleost fish: aromatase enzyme and mRNA expression identify glia as source, J. Neurosci., 21, 8943, 10.1523/JNEUROSCI.21-22-08943.2001 · DOI · Paper page
  92. Frade, 1998, Microglia-derived nerve growth factor causes cell death in the developing retina, Neuron, 20, 35, 10.1016/S0896-6273(00)80432-8 · DOI
  93. Fuzzati-Armentero, 2019, Peripheral-central neuroimmune crosstalk in Parkinson's disease: what do patients and animal models tell us?, Front Neurol., 10, 232, 10.3389/fneur.2019.00232 · DOI
  94. Gago, 2001, Progesterone and the oligodendroglial lineage: stage-dependent biosynthesis and metabolism, Glia, 36, 295, 10.1002/glia.1117 · DOI
  95. Gao, 2012, Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury, J. Trauma Acute Care Surg., 72, 643, 10.1097/TA.0b013e31823c54a6 · DOI
  96. Garay, 2007, Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis, J. Steroid. Biochem. Mol. Biol., 107, 228, 10.1016/j.jsbmb.2007.03.040 · DOI
  97. Garcia-Estrada, 1993, Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury, Brain Res., 628, 271, 10.1016/0006-8993(93)90964-O · DOI
  98. Garcia-Estrada, 1999, Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury, Int. J. Dev. Neurosci., 17, 145, 10.1016/S0736-5748(98)00065-3 · DOI
  99. Garg, 2017, Progesterone-mediated non-classical signaling, Trends Endocrinol. Metab., 28, 656, 10.1016/j.tem.2017.05.006 · DOI
  100. Garidou, 2004, Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis, J. Immunol., 173, 2435, 10.4049/jimmunol.173.4.2435 · DOI
  101. Gatson, 2012, Estrone is neuroprotective in rats after traumatic brain injury, J. Neurotrauma., 29, 2209, 10.1089/neu.2011.2274 · DOI
  102. Ghisletti, 2005, 17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization, Mol. Cell. Biol., 25, 2957, 10.1128/MCB.25.8.2957-2968.2005 · DOI
  103. Giatti, 2010, Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels, Neurochem. Int., 56, 118, 10.1016/j.neuint.2009.09.009 · DOI
  104. Giatti, 2012, Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis, J. Neuroendocrinol., 24, 851, 10.1111/j.1365-2826.2012.02284.x · DOI
  105. Glajch, 2016, microneurotrophins improve survival in motor neuron-astrocyte co-cultures but do not improve disease phenotypes in a mutant sod1 mouse model of amyotrophic lateral sclerosis, PLoS ONE, 11, e0164103, 10.1371/journal.pone.0164103 · DOI
  106. Glass, 2010, Mechanisms underlying inflammation in neurodegeneration, Cell, 140, 918, 10.1016/j.cell.2010.02.016 · DOI · Paper page
  107. Gold, 2009, Estrogen and testosterone therapies in multiple sclerosis, Prog. Brain Res., 175, 239, 10.1016/S0079-6123(09)17516-7 · DOI
  108. Gold, 2009, Estrogen treatment in multiple sclerosis, J. Neurol. Sci., 286, 99, 10.1016/j.jns.2009.05.028 · DOI
  109. Goldmann, 2013, A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation, Nat. Neurosci., 16, 1618, 10.1038/nn.3531 · DOI · Paper page
  110. Gomez-Mancilla, 1992, Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys, Neurosci. Lett., 135, 129, 10.1016/0304-3940(92)90152-W · DOI
  111. Goris, 2003, New candidate loci for multiple sclerosis susceptibility revealed by a whole genome association screen in a Belgian population, J. Neuroimmunol., 143, 65, 10.1016/j.jneuroim.2003.08.013 · DOI
  112. Gottfried-Blackmore, 2008, Brain microglia express steroid-converting enzymes in the mouse, J. Steroid. Biochem. Mol. Biol., 109, 96, 10.1016/j.jsbmb.2007.12.013 · DOI
  113. Gravanis, 2017, Synthetic microneurotrophins in therapeutics of neurodegeneration, Oncotarget., 8, 9005, 10.18632/oncotarget.14667 · DOI
  114. Guadagno, 2013, Microglia-derived TNFalpha induces apoptosis in neural precursor cells via transcriptional activation of the Bcl-2 family member Puma, Cell Death Dis., 4, e538, 10.1038/cddis.2013.59 · DOI
  115. Guan, 2017, GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease, NeuroImmunoModulation, 24, 60, 10.1159/000478908 · DOI · Paper page
  116. Gyoneva, 2015, Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines, Trends. Pharmacol. Sci., 36, 471, 10.1016/j.tips.2015.04.003 · DOI
  117. Habib, 2014, Regulation of hypoxia-induced inflammatory responses and M1–M2 phenotype switch of primary rat microglia by sex steroids, J. Mol. Neurosci., 52, 277, 10.1007/s12031-013-0137-y · DOI
  118. Hampl, 2010, Neuroimmunomodulatory steroids in Alzheimer dementia, J. Steroid. Biochem., 119, 97, 10.1016/j.jsbmb.2010.02.007 · DOI
  119. He, 2004, Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury, Exp. Neurol., 189, 404, 10.1016/j.expneurol.2004.06.008 · DOI
  120. Henderson, 2014, Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause, J. Steroid. Biochem. Mol. Biol., 142, 99, 10.1016/j.jsbmb.2013.05.010 · DOI
  121. Hernandez-Ontiveros, 2013, Microglia activation as a biomarker for traumatic brain injury, Front. Neurol., 4, 30, 10.3389/fneur.2013.00030 · DOI
  122. Hillen, 2000, DHEA-S plasma levels and incidence of Alzheimer's disease, Biol. Psychiatry., 47, 161, 10.1016/S0006-3223(99)00217-6 · DOI
  123. Hoffman, 2003, The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats, J. Neurotrauma., 20, 859, 10.1089/089771503322385791 · DOI
  124. Hong, 2016, Progesterone exerts neuroprotective effects against Abeta-induced neuroinflammation by attenuating ER stress in astrocytes, Int. Immunopharmacol., 33, 83, 10.1016/j.intimp.2016.02.002 · DOI
  125. Hong, 2018, Progesterone suppresses Abeta42-induced neuroinflammation by enhancing autophagy in astrocytes, Int. Immunopharmacol., 54, 336, 10.1016/j.intimp.2017.11.044 · DOI
  126. Hsieh, 2009, Mechanism of the salutary effects of estrogen on kupffer cell phagocytic capacity following trauma-hemorrhage: pivotal role of Akt activation, J. Immunol., 182, 4406, 10.4049/jimmunol.0803423 · DOI
  127. Hua, 2011, Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: effect of exogenous progesterone, J. Neuroinflammation, 8, 42, 10.1186/1742-2094-8-42 · DOI
  128. Hussain, 2011, Progesterone and nestorone facilitate axon remyelination: a role for progesterone receptors, Endocrinology, 152, 3820, 10.1210/en.2011-1219 · DOI · Paper page
  129. Iban-Arias, 2018, The synthetic microneurotrophin BNN27 affects retinal function in rats with streptozotocin-induced diabetes, Diabetes, 67, 321, 10.2337/db17-0391 · DOI
  130. Imtiaz, 2017, Postmenopausal hormone therapy and Alzheimer disease: a prospective cohort study, Neurology, 88, 1062, 10.1212/WNL.0000000000003696 · DOI
  131. Ishihara, 2015, Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway, J. Steroid. Biochem. Mol. Biol., 145, 85, 10.1016/j.jsbmb.2014.10.002 · DOI
  132. Ishii, 2009, Epigenetic regulation of the alternatively activated macrophage phenotype, Blood, 114, 3244, 10.1182/blood-2009-04-217620 · DOI
  133. Ito, 2001, Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice, J. Immunol., 167, 542, 10.4049/jimmunol.167.1.542 · DOI
  134. Jacobsen, 2012, Progesterone receptors, their isoforms and progesterone regulated transcription, Mol. Cell Endocrinol., 357, 18, 10.1016/j.mce.2011.09.016 · DOI
  135. Janicki, 2010, Hormonal influences on cognition and risk for Alzheimer's disease, Curr. Neurol. Neurosci. Rep., 10, 359, 10.1007/s11910-010-0122-6 · DOI
  136. Jodhka, 2009, The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression, Endocrinology, 150, 3162, 10.1210/en.2008-1247 · DOI
  137. Jones, 2017, Peripherally induced regulatory T cells: recruited protectors of the central nervous system against autoimmune neuroinflammation, Front. Immunol., 8, 532, 10.3389/fimmu.2017.00532 · DOI
  138. Joniec, 2009, Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Brain Res., 1261, 7, 10.1016/j.brainres.2008.12.081 · DOI
  139. Kampa, 2008, Membrane-initiated steroid action in breast and prostate cancer, Steroids, 73, 953, 10.1016/j.steroids.2007.12.009 · DOI
  140. Kampa, 2013, The estrogen receptor: two or more molecules, multiple variants, diverse localizations, signaling and functions. Are we undergoing a paradigm-shift as regards their significance in breast cancer?, Hormones (Athens), 12, 69, 10.1007/BF03401288 · DOI
  141. Kaur, 2007, Progesterone increases brain-derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants, J. Neurosci. Res., 85, 2441, 10.1002/jnr.21370 · DOI
  142. Khaksari, 2011, The role of estrogen and progesterone, administered alone and in combination, in modulating cytokine concentration following traumatic brain injury, Can. J. Physiol. Pharmacol., 89, 31, 10.1139/Y10-103 · DOI
  143. Khaksari, 2015, Changes in the gene expression of estrogen receptors involved in the protective effect of estrogen in rat's trumatic brain injury, Brain Res., 1618, 1, 10.1016/j.brainres.2015.05.017 · DOI
  144. Khaksari, 2018, Effects of female sex steroids administration on pathophysiologic mechanisms in traumatic brain injury, Transl Stroke Res., 9, 393, 10.1007/s12975-017-0588-5 · DOI
  145. Kipp, 2009, Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis, Front. Neuroendocrinol., 30, 188, 10.1016/j.yfrne.2009.04.004 · DOI
  146. Kipp, 2007, Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factor-alpha and interleukin-18 in midbrain astrocytes, J. Neuroendocrinol., 19, 819, 10.1111/j.1365-2826.2007.01588.x · DOI · Paper page
  147. Kortekaas, 2005, Blood-brain barrier dysfunction in parkinsonian midbrain in vivo, Ann. Neurol., 57, 176, 10.1002/ana.20369 · DOI · Paper page
  148. Krentzel, 2015, Sex differences and rapid estrogen signaling: a look at songbird audition, Front. Neuroendocrinol., 38, 37, 10.1016/j.yfrne.2015.01.001 · DOI
  149. Kuo, 2010, Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes, J. Neurosci., 30, 12950, 10.1523/JNEUROSCI.1158-10.2010 · DOI
  150. Kyritsis, 2012, Acute inflammation initiates the regenerative response in the adult zebrafish brain, Science, 338, 1353, 10.1126/science.1228773 · DOI
  151. Lambert, 2003, Neurosteroid modulation of GABAA receptors, Prog. Neurobiol., 71, 67, 10.1016/j.pneurobio.2003.09.001 · DOI
  152. Langer, 2012, Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis, Circ. Res., 110, 1202, 10.1161/CIRCRESAHA.111.256370 · DOI
  153. Langston, 2006, The Parkinson's complex: parkinsonism is just the tip of the iceberg, Ann Neurol., 59, 591, 10.1002/ana.20834 · DOI
  154. Lavisse, 2012, Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging, J. Neurosci., 32, 10809, 10.1523/JNEUROSCI.1487-12.2012 · DOI
  155. Lazaridis, 2011, Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis, PLoS Biol., 9, e1001051, 10.1371/journal.pbio.1001051 · DOI
  156. Lebesgue, 2006, Effects of estradiol on cognition and hippocampal pathology after lateral fluid percussion brain injury in female rats, J. Neurotrauma., 23, 1814, 10.1089/neu.2006.23.1814 · DOI
  157. Lee, 2011, Astrocytes are GABAergic cells that modulate microglial activity, Glia, 59, 152, 10.1002/glia.21087 · DOI
  158. Lei, 2014, Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia, PLoS ONE, 9, e103969, 10.1371/journal.pone.0103969 · DOI
  159. Li, 2013, Enhanced cortical expression of myeloid differentiation primary response protein 88 (Myd88) in patients with traumatic brain injury, J. Surg. Res., 180, 133, 10.1016/j.jss.2012.10.928 · DOI
  160. Li, 2002, Estrogen enhances uptake of amyloid β-protein by microglia derived from the human cortex, J. Neurochem., 75, 1447, 10.1046/j.1471-4159.2000.0751447.x · DOI
  161. Li, 2010, DHEA prevents Abeta25-35-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI3K-Akt-mTOR signaling, Neuropharmacology, 59, 323, 10.1016/j.neuropharm.2010.02.009 · DOI
  162. Lin, 2015, Efficacy of progesterone for moderate to severe traumatic brain injury: a meta-analysis of randomized clinical trials, Sci. Rep., 5, 13442, 10.1038/srep13442 · DOI
  163. Litim, 2017, Effects of progesterone administered after MPTP on dopaminergic neurons of male mice, Neuropharmacology, 117, 209, 10.1016/j.neuropharm.2017.02.007 · DOI
  164. Liu, 2014, Female reproductive factors, menopausal hormone use, and Parkinson's disease, Mov. Disord., 29, 889, 10.1002/mds.25771 · DOI
  165. Liu, 2002, Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3), J. Biol. Chem., 277, 21379, 10.1074/jbc.M200491200 · DOI
  166. Liu, 2004, Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor, Steroids, 69, 279, 10.1016/j.steroids.2004.02.004 · DOI
  167. Liu, 2007, Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease, Clin. Exp. Pharmacol. Physiol., 34, 555, 10.1111/j.1440-1681.2007.04616.x · DOI
  168. Liu, 2005, Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia, J. Neurosci. Res., 81, 653, 10.1002/jnr.20583 · DOI
  169. Liu, 2014, The 18 kDa translocator protein, microglia and neuroinflammation, Brain Pathol., 24, 631, 10.1111/bpa.12196 · DOI
  170. Liu, 2013, Metabolic alteration of neuroactive steroids and protective effect of progesterone in Alzheimer's disease-like rats, Neural Regen Res., 8, 2800
  171. Liu, 2013, Estrogen-induced nongenomic calcium signaling inhibits lipopolysaccharide-stimulated tumor necrosis factor alpha production in macrophages, PLoS ONE, 8, e83072, 10.1371/journal.pone.0083072 · DOI
  172. London, 2010, Genomic and neural analysis of the estradiol-synthetic pathway in the zebra finch, BMC Neurosci., 11, 46, 10.1186/1471-2202-11-46 · DOI
  173. London, 2006, Widespread capacity for steroid synthesis in the avian brain and song system, Endocrinology, 147, 5975, 10.1210/en.2006-0154 · DOI
  174. Lopez Rodriguez, 2011, Estradiol decreases cortical reactive astrogliosis after brain injury by a mechanism involving cannabinoid receptors, Cereb Cortex., 21, 2046, 10.1093/cercor/bhq277 · DOI
  175. Lopez-Rodriguez, 2015, Correlation of brain levels of progesterone and dehydroepiandrosterone with neurological recovery after traumatic brain injury in female mice, Psychoneuroendocrinology., 56, 1, 10.1016/j.psyneuen.2015.02.018 · DOI
  176. Lu, 2018, 17beta-estradiol rescues damages following traumatic brain injury from molecule to behavior in mice, J. Cell Physiol., 233, 1712, 10.1002/jcp.26083 · DOI
  177. Luchetti, 2011, Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis, Neuroscience, 191, 6, 10.1016/j.neuroscience.2011.04.010 · DOI
  178. Luchetti, 2014, Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions, J. Neuropathol. Exp. Neurol., 73, 123, 10.1097/NEN.0000000000000037 · DOI
  179. Maggio, 2015, DHEA and cognitive function in the elderly, J. Steroid. Biochem. Mol. Biol., 145, 281, 10.1016/j.jsbmb.2014.03.014 · DOI
  180. Malik, 2003, A novel dehydroepiandrosterone analog improves functional recovery in a rat traumatic brain injury model, J. Neurotrauma., 20, 463, 10.1089/089771503765355531 · DOI
  181. Maninger, 2009, Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS), Front. Neuroendocrinol., 30, 65, 10.1016/j.yfrne.2008.11.002 · DOI · Paper page
  182. Martin-Jimenez, 2018, Astrocytes mediate protective actions of estrogenic compounds after traumatic brain injury, Neuroendocrinology
  183. Marx, 2006, Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics, Neuropsychopharmacology, 31, 1249, 10.1038/sj.npp.1300952 · DOI
  184. Matejuk, 2001, 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis, J. Neurosci. Res., 65, 529, 10.1002/jnr.1183 · DOI
  185. Mathys, 2017, Temporal tracking of microglia activation in neurodegeneration at single-cell resolution, Cell Rep., 21, 366, 10.1016/j.celrep.2017.09.039 · DOI · Paper page
  186. Matsunaga, 2004, 7alpha-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system, Proc. Natl. Acad. Sci. USA, 101, 17282, 10.1073/pnas.0407176101 · DOI
  187. McKinney, 2017, Using induced pluripotent stem cells derived neurons to model brain diseases, Neural Regen Res., 12, 1062, 10.4103/1673-5374.211180 · DOI
  188. Meffre, 2005, The membrane-associated progesterone-binding protein 25-Dx is expressed in brain regions involved in water homeostasis and is up-regulated after traumatic brain injury, J. Neurochem., 93, 1314, 10.1111/j.1471-4159.2005.03127.x · DOI
  189. Meffre, 2013, Distribution of membrane progesterone receptor alpha in the male mouse and rat brain and its regulation after traumatic brain injury, Neuroscience, 231, 111, 10.1016/j.neuroscience.2012.11.039 · DOI
  190. Melcangi, 2012, Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease, J. Mol. Neurosci., 46, 177, 10.1007/s12031-011-9570-y · DOI
  191. Mellon, 2002, Neurosteroids: biochemistry and clinical significance, Trends Endocrinol. Metab., 13, 35, 10.1016/S1043-2760(01)00503-3 · DOI · Paper page
  192. Mendell, 2018, Neurosteroid metabolites of gonadal steroid hormones in neuroprotection: implications for sex differences in neurodegenerative disease, Front. Mol. Neurosci., 11, 359, 10.3389/fnmol.2018.00359 · DOI
  193. Mensah-Nyagan, 1996, Localization of 17beta-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog, Proc. Natl. Acad. Sci. USA, 93, 1423, 10.1073/pnas.93.4.1423 · DOI
  194. Mifflin, 2018, Effect of voluntary wheel running on neuroactive steroid levels in murine experimental autoimmune encephalomyelitis, Neurosci. Lett., 685, 150, 10.1016/j.neulet.2018.08.040 · DOI
  195. Migliore, 2009, Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases, Mutat. Res., 667, 82, 10.1016/j.mrfmmm.2008.10.011 · DOI
  196. Milman, 2008, DHEAS repeated treatment improves cognitive and behavioral deficits after mild traumatic brain injury, Eur. Neuropsychopharmacol., 18, 181, 10.1016/j.euroneuro.2007.05.007 · DOI
  197. Mirzatoni, 2010, Injury-induced regulation of steroidogenic gene expression in the cerebellum, J. Neurotrauma., 27, 1875, 10.1089/neu.2010.1330 · DOI
  198. Miura, 2003, Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection, Proc. Natl. Acad. Sci. USA, 100, 2777, 10.1073/pnas.2628048100 · DOI
  199. Morales, 2016, The astrocytic response to the dopaminergic denervation of the striatum, J. Neurochem., 139, 81, 10.1111/jnc.13684 · DOI
  200. Muller, 2006, Progesterone and its metabolites 5-dihydroprogesterone and 5-3-tetrahydroprogesterone decrease LPS-induced NO release in the murine microglial cell line, BV-2, Neuro Endocrinol. Lett., 27, 675

200 of 297 shown

Cited by

See all 213

Metadata

Authors
Yilmaz, C., Karali, K., Fodelianaki, G., Gravanis, A., Chavakis, T., Charalampopoulos, I., & Alexaki, V. I.
Venue
Frontiers in Neuroendocrinology
Publisher
Elsevier BV
Published
2019-10
Volume
55
Pages
100788
ISSN
0091-3022
DOI
10.1016/j.yfrne.2019.100788
Cited by
213
References
61
Language
en
Licence
Funders
  • Horizon 2020
  • Deutsche Forschungsgemeinschaft

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.